Published trade mark details for 2540783
This information was published on 2025-05-02T15:15:51 for IP Right Acceptance Published.
| Field | Value |
| (210) | 2540783 (IR 1850158) |
| (220) |
03 Dec 2024
|
| (300) |
US, 25 Jun 2024, 98617883
|
| (500) |
The mark consists of stylized Alpha and Omega design.
|
| (511) (510) |
Class 5
Biological and pharmaceutical preparations for the treatment of transplant complications, ischemia-reperfusion injury, and endothelial, renal, cardiovascular, infectious, hematological, oncological, pulmonary, autoimmune, neurological, psychiatric, endocrine, metabolic, inflammatory, immunological, ocular, and addiction- and compulsion-related diseases and disorders. Class 42 Medical and scientific research, namely conducting clinical trials; pharmaceutical research and development. |
| (540) |
|
| (550) | Figurative |
| (730) |
Omeros Corporation
|
Find out more about publications on the About page.